MAPK pathway: A potential target for the treatment of non-small-cell lung carcinoma

Pradhan, R Singhvi, G Dubey, SK Gupta, G Dua, K

Permalink

Closed Access

	Filename	Description	Size
	fmc-2018-0468.pdf	Published Version	170.69 kB	Adobe PDF	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Pradhan, R	en_US
dc.contributor.author	Singhvi, G	en_US
dc.contributor.author	Dubey, SK	en_US
dc.contributor.author	Gupta, G	en_US
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159	en_US
dc.date.issued	2019-04-01	en_US
dc.identifier.citation	Future Medicinal Chemistry, 2019, 11 (8), pp. 793 - 795	en_US
dc.identifier.issn	1756-8919	en_US
dc.identifier.uri	http://hdl.handle.net/10453/136295
dc.relation.ispartof	Future Medicinal Chemistry	en_US
dc.relation.isbasedon	10.4155/fmc-2018-0468	en_US
dc.subject.classification	Medicinal & Biomolecular Chemistry	en_US
dc.subject.mesh	Animals	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Carcinoma, Non-Small-Cell Lung	en_US
dc.subject.mesh	Lung Neoplasms	en_US
dc.subject.mesh	Antineoplastic Agents	en_US
dc.subject.mesh	MAP Kinase Signaling System	en_US
dc.subject.mesh	Molecular Targeted Therapy	en_US
dc.subject.mesh	ErbB Receptors	en_US
dc.title	MAPK pathway: A potential target for the treatment of non-small-cell lung carcinoma	en_US
dc.type	Journal Article
utslib.citation.volume	8	en_US
utslib.citation.volume	11	en_US
utslib.for	0304 Medicinal and Biomolecular Chemistry	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.issue	8	en_US
pubs.publication-status	Published	en_US
pubs.volume	11	en_US

Please use this identifier to cite or link to this item: